A prospective study reveals that decreased tryptophan levels in portal circulation induce neutrophil hyperactivation in alcoholic liver disease. In vitro supplementation with tryptophan ameliorated neutrophil activation, identifying the gut-liver metabolic crosstalk as a potential therapeutic target for mitigating neutrophil-driven liver injury.